New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 14, 2014
09:17 EDTCONXCorgenix Medical announces transfer, product development agreement with Mellitus
Corgenix Medical Corporation announced a technology transfer and product development agreement with Mellitus LLC of Cambridge, Mass. Mellitus is a private company that is developing a novel in vitro diagnostic test with potential clinical utility for diabetes. The test is based on the measurement of Glycated CD59. Under terms of the agreement, Corgenix will develop a test kit to measure GCD59 for Mellitus’ U.S. and European Union commercialization programs. Mellitus’ lead product candidate is a test for Gestational Diabetes Mellitus.
News For CONX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CONX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use